Greater Kassel Area
Bio Phycisist with many years of experience in Aerosol Medicine and Pulmonary Drug Delivery. Involved in different Pharmaceutical Developments in Inhalation Therapy. Regulatory Expert at EMA and serving on different scientific advicory boards of big Pharma Companies. President of International Society of Aerosols in Medicine (ISAM). Founder and CEO of Activaero a drug development company until acquisition by Vectura Group plc in March 2014. Founder of Inamed which is a CRO specialized in the field of respiratory diseases, Ventaleon which is a project company using inhaled LASAG to treat different respiratory viral infections and GS Bio-Inhalation GmbH a consulting company working as Business Angel in the life science field. Specialties: Pulmonary Deposition of inhaled Aerosols, In vitro in vivo correlation. Deposition measurements and modelling. Inhalation Product development. Supporting young Start Up teams as Business Angel with the experience of founding several companies.
Ventaleon is a pulmonary drug delivery company.
Activaero is a pulmonary drug development company, developing innovative drugs against severe lung diseases by using inhalation systems with active and passive breath control. Activaero intends to consolidate its place as the world leader in patient-friendly pulmonary drug delivery, revolutionizing the safety and efficacy of inhaled medicines. Activaero was acquired by Vectura plc in March 2014.